Further extension of completion date of major transaction in relation to deemed disposal of equity interest in henan Fusen Pharmaceutical company limited
Filed with HKEX · Stock code 1652 · · 2 pages · English
Summary by 6ix AI
Fusen Pharmaceutical Co., Ltd. has announced a further extension of the completion date for a major transaction related to the deemed disposal of equity interest in Henan Fusen Pharmaceutical Company Limited. The new completion date for the Capital Increase Price Payment has been extended to a date falling on or before the end of October. This extension is due to the need for additional time for investors to finalize their internal arrangements for payment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Fusen Pharmaceutical Co., Ltd. on 6ix
Earlier from Fusen Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Notification Letter to Non-Registered Holders and Reply Form - Notice of Publication of Interim Report
- Notification Letter to Registered Shareholders and Reply Form - Notice of Publication of Interim Report
- Interim Report 2026
- Fusen Pharmaceutical: Proposals for general mandates to issue shares and repurchase shares, re-election of directors, re-appointment of auditors, declaration of final dividend, amendments to the memorandum and the articles, adoption of the amended and restated memorandum and articles of association and notice of annual general meeting
Follow Fusen Pharmaceutical into a list and get an email when it puts out news.
Follow Fusen Pharmaceutical